Literature DB >> 18064330

Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.

Christina Perneby1, N Håkan Wallén, Claes Hofman-Bang, Per Tornvall, Torbjörn Ivert, Nailin Li, Paul Hjemdahl.   

Abstract

Stress may counteract responses to antiplatelet drug treatment. We investigated if adding clopidogrel to aspirin treatment could attenutate stress-induced platelet activation and myocardial ischemia in patients with coronary artery disease (CAD). Thirty-one male patients with documented CAD-treated with aspirin (75-160 mg daily) were randomized to co-treatment with clopidogrel (n = 16) or placebo (n = 15). A symptom-limited exercise test and 48-hour (h) Holter monitoring were performed before and after two weeks of double-blind treatment. Platelet function was assessed by flow cytometry and impedance aggregometry in whole blood. Exercise-induced and ambulatory ischemia was assessed from electrocardiographic (ECG) recordings. Clopidogrel treatment inhibited ADP-induced platelet P-selectin expression by 64% (22-87%), and attenuated the P-selectin response to thrombin (p < 0.001), and platelet aggregation induced by low-dose collagen (p < 0.01). Exercise ( approximately 110W) increased heart rate similarly, and caused approximately 1.8 mm ST-segment depression both before and after treatment. Exercise caused platelet activation, i.e. increased circulating activated single platelets and platelet-platelet aggregates, enhanced the in-vitro responsiveness to ADP or thrombin stimulation, and increased platelet-leukocyte aggregation. Clopidogrel inhibited ADP-induced platelet activation to a similar relative degree at rest and during exercise, but did not attenuate the platelet activating effect of exercise. Addition of clopidogrel to aspirin treatment did not attenuate either ambulatory or exercise-induced ischemia. In conclusion, adding clopidogrel to aspirin treatment inhibited platelet activation by both ADP, thrombin and collagen in vitro, but did not influence the prothrombotic responses to exercise. Intensified antiplatelet treatment did not reduce ECG signs of either exercise-induced or ambulatory myocardial ischemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18064330     DOI: 10.1160/th07-05-0323

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Platelet hyperactivity during exercise leading to iterative coronary stent thrombosis: clinical implications.

Authors:  Olivier Ormezzano; Benoit Polack; Gérald Vanzetto; Mohamed Sahnoun; Jacques Machecourt
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

Review 2.  Thrombosis, physical activity, and acute coronary syndromes.

Authors:  Arun Kumar; Subrata Kar; William P Fay
Journal:  J Appl Physiol (1985)       Date:  2011-05-19

3.  The influence of clopidogrel on ischemia diagnosed by myocardial perfusion stress testing.

Authors:  Ion S Jovin; Keita A Ebisu; Adriana D Oprea; Cynthia A Brandt; Donna Natale; Laurie A Finta; James Dziura; Frans J Wackers
Journal:  J Nucl Cardiol       Date:  2015-09-04       Impact factor: 5.952

4.  Does clopidogrel affect the efficacy of myocardial perfusion imaging?

Authors:  Paco E Bravo; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2015-09-04       Impact factor: 5.952

5.  PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.

Authors:  James T Willerson; Greg Cable; Edward T H Yeh
Journal:  Tex Heart Inst J       Date:  2009

6.  Influence of exercise test on platelet function in patients with coronary arterial disease: A systematic review.

Authors:  Chunhua Mo; Yanhui Wang; Zong Yue; Dayi Hu; Chun Yin
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.889

Review 7.  Platelet-Leucocyte Aggregates as Novel Biomarkers in Cardiovascular Diseases.

Authors:  Kinga Pluta; Kinga Porębska; Tomasz Urbanowicz; Aleksandra Gąsecka; Anna Olasińska-Wiśniewska; Radosław Targoński; Aleksandra Krasińska; Krzysztof J Filipiak; Marek Jemielity; Zbigniew Krasiński
Journal:  Biology (Basel)       Date:  2022-01-30

8.  Influence of cardiopulmonary exercise test on platelet function in patients with coronary artery diseases on antiplatelet therapy.

Authors:  Chun Yin; Yanhui Wang; Chunhua Mo; Zong Yue; Yihong Sun; Dayi Hu
Journal:  BMC Cardiovasc Disord       Date:  2022-03-04       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.